Collectively, the findings indicate that the expression NRF1 and CPT1 in NK cells is a key immunometabolic feature significantly associated with the risk of nosocomial infection in patients with CCI, and suggest that NK cell-specific immunometabolic features may be applied for assessing the risk of nosocomial infection development. This evidence concerns the gene CPT1A and nosocomial infection.